查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433543

霉浆菌检测市场规模、份额和趋势分析：2024-2030 年按产品、技术、应用、最终用途、地区和细分市场进行的预测

Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kits & Reagents), By Technology (PCR, ELISA, Direct Assay, Microbial Culture), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

霉浆菌检测市场成长与趋势：

根据Grand View Research, Inc.最新报告显示，到2030年，全球霉浆菌检测市场规模预计将达到22.6亿美元，预测期内复合年增长率为13.58%。

推动市场扩张的主要因素包括生物製造、新兴国家对霉浆菌检测的需求增加以及药品外包的扩大。此外，细胞株污染的增加、技术创新和生物科学研究也推动了整体市场的成长。

越来越多的政府倡议支持製药和生技公司也推动了市场成长。美国FDA提案取消在体外活细胞培养中检测霉浆菌的测试，并指出只有单一测试才能辨识支原体。生技药品法规的这些变化预计将提高霉浆菌检测测试的特异性和敏感性，并导致产业中新技术的引入。预计这将为新产品开发的主要参与者创造巨大的机会。

年终COVID-19 大流行期间，肺炎霉浆菌阳性率急剧下降。这是对 COVID-19 大流行采取严格监管的结果，成功阻止了肺炎支原体的传播。然而，在放鬆COVID-19限制后，肺炎支原体预计将在整个研究期间进一步传播，这将对霉浆菌检测市场的成长产生积极影响。

增加研发投资对市场收益的扩张做出了重大贡献。随着医疗保健支出的增加，生命科学产业的研究活动显着增加。药物发现和开发新技术的采用以及细胞培养技术的创新正在推动霉浆菌检测的需求。细胞培养物污染的高风险是预计在预测期内推动霉浆菌检测市场的主要因素。

据估计，霉浆菌污染了全世界约 15% 至 35% 的连续细胞培养物。已知霉浆菌有 190 多种，但只有 8 种支原体造成了 95% 以上的细胞培养污染。不良的培养方法、气溶胶、灰尘以及层流故障或破裂导致的交叉污染是导致细胞培养污染案例数量不断增加的一些因素。这些因素预计将推动霉浆菌检测解决方案的市场需求。

霉浆菌检测市场报告亮点

  • 以产品来看，套件和试剂占据市场主导地位，预计在整个预测期内将呈现最快的复合年增长率。
  • PCR 方法的主要优点是操作简单且检测快速。
  • 从应用来看，由于细胞培养领域所进行的研究计划增加，细胞株检测领域在2023年占据最大份额，为41.65%。
  • 霉浆菌污染会引起细胞培养代谢物的变化并导致毒素的产生。因此，细胞株测试和认证在製药和生物製药行业变得越来越重要。
  • 北美地区占比最大，2023年为39.04%。这主要是由于大量参与企业市场、研发成本增加以及联邦援助。
  • 由于目标疾病盛行率上升以及随着人口老化而提高的认识等因素，预计亚太地区将在预测期内实现最高的成长率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势及展望
  • 市场动态
    • 生命科学领域研发投入增加
    • 政府加大对製药和生技产业的支持
    • 细胞培养物污染增加
    • 对危及生命疾病的有效治疗方法的需求不断增加
    • 市场竞争加剧
  • 市场限制因素分析
    • 细胞生物学研究成本高昂
    • 霉浆菌生长缓慢
    • 假阴性结果的可能性
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第四章 产品经营分析

  • 霉浆菌检测市场：产品变异分析
  • 装置
    • 2018-2030年设备市场
  • 套件和试剂
    • 套件和试剂市场，2018-2030
    • PCR检测
    • 核酸检测套件
    • 污垢
    • 拆卸套件
    • 标准和控制
    • 其他的
  • 服务
    • 服务市场，2018-2030（百万美元）

第五章技术业务分析

  • 霉浆菌检测市场：技术变革分析
  • PCR
  • 酵素连结免疫吸附试验
  • 直接测定
  • 间接测定
  • 微生物培养技术
  • 酵素法

第六章 应用业务分析

  • 霉浆菌检测市场：应用变化分析
  • 细胞株测试
    • 细胞株测试市场，2018-2030
  • 病毒检测
    • 病毒检测市场，2018-2030
  • 测试寿命终止的细胞
    • 报废电池检测市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第七章 最终用途业务分析

  • 霉浆菌测试市场：最终用途变异分析
  • 製药和生物技术公司
  • 细胞库
  • 合约研究组织
  • 学术研究所
  • 其他的

第八章区域业务分析

  • 2023 年及 2030 年霉浆菌检测市场占有率占有率（按地区）
  • 北美洲
    • SWOT分析
    • 北美霉浆菌检测市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 欧洲霉浆菌检测市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
    • 俄罗斯
  • 亚太地区
    • SWOT分析
    • 亚太地区霉浆菌检测市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
    • 新加坡
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲霉浆菌检测市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • SWOT分析
    • MEA霉浆菌检测市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争形势

  • 公司分类
  • 策略规划
    • 新产品发布
    • 合伙
    • 获得
    • 合作
    • 资金筹措
  • 2023年主要企业市场占有率分析
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Merck &Co., Inc.
    • Lonza Group AG
    • Charles River Laboratories International, Inc.
    • PromoCell GmbH
    • Asahi Kasei Medical Co., Ltd.
    • Sartorius AG
    • InvivoGen
    • Eurofins Scientific
    • （ATCC）American Type Culture Collection
Product Code: GVR-1-68038-897-8

Mycoplasma Testing Market Growth & Trends:

The global mycoplasma testing market size is expected to reach USD 2.26 billion by 2030, registering a CAGR of 13.58% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the expansion of market includes growing demand for mycoplasma testing in biomanufacturing, emerging economies, and growing pharmaceutical outsourcing. Additionally, the market's overall growth is driven by rising cell-line contamination and innovation & research in biological sciences.

Growing number of government initiatives to support pharmaceutical and biotechnology companies is also driving the market growth. The U.S. FDA proposed to remove a test for detecting mycoplasma within in vitro living cell cultures, as it can help identify only a single test method. These changes in biologics regulations are anticipated to improve specificity and sensitivity in mycoplasma detection tests, leading to introduction of new technologies in the industry. This is expected to create immense opportunities for key players in new product development.

The rates of M. pneumoniae positivity sharply decreased during the COVID-19 pandemic outbreak at the end of 2019. This was a result of the COVID-19 pandemic's stringent regulations, which successfully stopped the spread of M. pneumonia. However, it is anticipated that M. pneumonia will expand even more throughout the research period following the relaxation of COVID-19 limits, which will have a positive impact on the mycoplasma testing market's growth.

Increasing investments in R&D have contributed significantly to the market's revenue growth. With rising healthcare expenditure, research activities in the life sciences industry are increasing significantly. The adoption of new technologies for drug discovery & development and innovations in cell culture technologies are driving the demand for mycoplasma tests. The high risk of cell culture contamination remains the primary factor expected to drive the mycoplasma testing market over the forecast period

Mycoplasma is estimated to contaminate around 15%-35% of all continuous cell cultures around the world. Out of over 190 known species of mycoplasma, only eight species are responsible for more than 95% of cell culture contamination. Poor cultural practices, aerosols, dust, and cross-contamination as a result of faulty or broken laminar flow are some of the factors responsible for an increase in the number of cell culture contamination events. Such factors are likely to drive the market demand for mycoplasma testing solutions.

Mycoplasma Testing Market Report Highlights:

  • By product, kits and reagents dominated the market, and are anticipated to exhibit the fastest CAGR throughout the forecast period, due to their widespread use in mycoplasma testing
  • Ease of conducting the procedure and rapid detection are some of the major advantages offered by the PCR method
  • By application, the cell line testing segment held a largest share of 41.65% in 2023, owing to the increase in research projects being done in the field of cell culture
  • Mycoplasma contamination can cause alterations in cell culture metabolites and lead to development of toxins. This increases the importance of cell line testing and authentication in the pharmaceutical and biopharmaceutical industries
  • North America held the largest share of 39.04% in 2023. This is mostly attributed to the presence of significant market participants, as well as rising R&D spending and federal assistance
  • In Asia Pacific, the market is expected to grow at the highest rate in a projected time period driven by factors such as the rising prevalence of target diseases with an aging population, rising awareness and others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Test Segment
      • 1.1.1.2 Service Provider Segment
      • 1.1.1.3 Application Segment
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecasts Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing R&D investments in life sciences
    • 3.4.2. Rising government support toward pharmaceutical and biotechnology industries
    • 3.4.3. Rising cell culture contamination
    • 3.4.4. Growing demand for the introduction of effective treatment of life-threatening diseases
    • 3.4.5. Increased competition in the market
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of research in cell biology
    • 3.5.2. Slow rate of mycoplasma growth
    • 3.5.3. Possibility of false negative results
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Mycoplasma Testing Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
    • 4.3.2. PCR Assays
      • 4.3.2.1. PCR Assays Market, 2018 - 2030 (USD Million)
    • 4.3.3. Nucleic Acid Detection Kits
      • 4.3.3.1. Nucleic Acid Detection Kits Market, 2018 - 2030 (USD Million)
    • 4.3.4. Stains
      • 4.3.4.1. Stains Market, 2018 - 2030 (USD Million)
    • 4.3.5. Elimination Kits
      • 4.3.5.1. Elimination Kits Market, 2018 - 2030 (USD Million)
    • 4.3.6. Standards & Controls
      • 4.3.6.1. Standards & Controls Market, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Million

Chapter 5. Technology Business Analysis

  • 5.1. Mycoplasma Testing Market: Technology Movement Analysis
  • 5.2. PCR
    • 5.2.1. PCR Market, 2018 - 2030 (USD Million)
  • 5.3. ELISA
    • 5.3.1. ELISA Market, 2018 - 2030 (USD Million)
  • 5.4. Direct Assay
    • 5.4.1. Direct Assay Market, 2018 - 2030 (USD Million)
  • 5.5. Indirect Assay
    • 5.5.1. Indirect Assay Market, 2018 - 2030 (USD Million)
  • 5.6. Microbial Culture Techniques
    • 5.6.1. Microbial Culture Techniques Market, 2018 - 2030 (USD Million)
  • 5.7. Enzymatic Methods
    • 5.7.1. Enzymatic Methods Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Mycoplasma Testing Market: Application Movement Analysis
  • 6.2. Cell Line Testing
    • 6.2.1. Cell Line Testing Market, 2018 - 2030 (USD Million)
  • 6.3. Virus Testing
    • 6.3.1. Virus Testing Market, 2018 - 2030 (USD Million)
  • 6.4. End of Production Cells Testing
    • 6.4.1. End of Production Cells Testing Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

  • 7.1. Mycoplasma Testing Market: End-use Movement Analysis
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.3. Cell Banks
    • 7.3.1. Cell Banks Market, 2018 - 2030 (USD Million)
  • 7.4. Contract Research Organizations
    • 7.4.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Mycoplasma Testing Market Share By Region, 2023 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. U.S. Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Canada Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. UK Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. France Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Italy Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Spain Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Denmark Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Sweden Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Reimbursement Scenario
      • 8.3.10.6. Norway Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.11. Russia
      • 8.3.11.1. Key Country Dynamics
      • 8.3.11.2. Target Disease Prevalence
      • 8.3.11.3. Competitive Scenario
      • 8.3.11.4. Regulatory Framework
      • 8.3.11.5. Reimbursement Scenario
      • 8.3.11.6. Russia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. Japan Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. China Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. India Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. South Korea Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Australia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Reimbursement Scenario
      • 8.4.8.6. Thailand Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.9. Singapore
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Target Disease Prevalence
      • 8.4.9.3. Competitive Scenario
      • 8.4.9.4. Regulatory Framework
      • 8.4.9.5. Reimbursement Scenario
      • 8.4.9.6. Singapore Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Brazil Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Reimbursement Scenario
      • 8.5.4.6. Mexico Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.5.5. Argentina
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. Reimbursement Scenario
      • 8.5.5.6. Argentina Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. South Africa Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. Saudi Arabia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. UAE Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Reimbursement Scenario
      • 8.6.6.6. Kuwait Mycoplasma Testing Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Strategy Mapping
    • 9.2.1 New Product Launch
    • 9.2.2 Partnerships
    • 9.2.3 Acquision
    • 9.2.4 Collaboration
    • 9.2.5 Funding
  • 9.3 Key Company Market Share Analysis, 2023
  • 9.4 Company Profiles
    • 9.4.1 Thermo Fisher Scientific, Inc.
      • 9.4.1.1 Company overview
      • 9.4.1.2 Financial performance
      • 9.4.1.3 Product benchmarking
      • 9.4.1.4 Strategic Initiatives
    • 9.4.2 Merck & Co., Inc.
      • 9.4.2.1 Company overview
      • 9.4.2.2 Financial performance
      • 9.4.2.3 Product benchmarking
      • 9.4.2.4 Strategic Initiatives
    • 9.4.3 Lonza Group AG
      • 9.4.3.1 Company overview
      • 9.4.3.2 Financial performance
      • 9.4.3.3 Product benchmarking
      • 9.4.3.4 Strategic Initiatives
    • 9.4.4 Charles River Laboratories International, Inc.
      • 9.4.4.1 Company overview
      • 9.4.4.2 Product benchmarking
      • 9.4.4.3 Strategic Initiatives
    • 9.4.5 PromoCell GmbH
      • 9.4.5.1 Company overview
      • 9.4.5.2 Financial performance
      • 9.4.5.3 Product benchmarking
      • 9.4.5.4 Strategic Initiatives
    • 9.4.6 Asahi Kasei Medical Co., Ltd.
      • 9.4.6.1 Company overview
      • 9.4.6.2 Financial performance
      • 9.4.6.3 Product benchmarking
      • 9.4.6.4 Strategic Initiatives
    • 9.4.7 Sartorius AG
      • 9.4.7.1 Company overview
      • 9.4.7.2 Financial performance
      • 9.4.7.3 Product benchmarking
      • 9.4.7.4 Strategic Initiatives
    • 9.4.8 InvivoGen
      • 9.4.8.1 Company overview
      • 9.4.8.2 Financial performance
      • 9.4.8.3 Product benchmarking
      • 9.4.8.4 Strategic Initiatives
    • 9.4.9 Eurofins Scientific
      • 9.4.9.1 Company overview
      • 9.4.9.2 Financial performance
      • 9.4.9.3 Product benchmarking
      • 9.4.9.4 Strategic Initiatives
    • 9.4.10 (ATCC) American Type Culture Collection
      • 9.4.10.1 Company overview
      • 9.4.10.2 Financial performance
      • 9.4.10.3 Product benchmarking
      • 9.4.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Mycoplasma Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7 Global Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 8 North America Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 17 Canada Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20 Canada Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 21 Europe Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Europe Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Europe Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 Germany Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Germany Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Germany Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 Germany Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 UK Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 UK Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 UK Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33 UK Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 France Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 France Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 France Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 France Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Italy Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Italy Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Italy Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Italy Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Spain Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Spain Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Spain Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 45 Spain Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 46 Denmark Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Denmark Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Denmark Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Denmark Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Sweden Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Sweden Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Sweden Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Sweden Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 Norway Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Norway Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Norway Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Norway Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Russia Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Russia Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Russia Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 61 Russia Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 China Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 China Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 China Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 China Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Japan Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Japan Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 Japan Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 75 India Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 India Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 77 India Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 India Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 79 South Korea Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Korea Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 South Korea Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 83 Australia Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 Australia Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 Australia Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Thailand Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90 Thailand Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 91 Singapore Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 Singapore Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 93 Singapore Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 Singapore Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 95 Latin America Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 96 Latin America Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Latin America Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 98 Latin America Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99 Latin America Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 100 Brazil Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Brazil Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 102 Brazil Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Brazil Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 104 Mexico Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 105 Mexico Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 106 Mexico Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 107 Mexico Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 108 Argentina Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 109 Argentina Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 110 Argentina Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 111 Argentina Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 112 Middle East & Africa Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Middle East & Africa Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Middle East & Africa Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Middle East & Africa Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Middle East & Africa Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 117 South Africa Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 South Africa Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 119 South Africa Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 120 South Africa Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Saudi Arabia Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Saudi Arabia Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Saudi Arabia Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 125 UAE Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 126 UAE Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 127 UAE Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 128 UAE Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 129 Kuwait Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 130 Kuwait Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 131 Kuwait Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 132 Kuwait Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Mycoplasma Testing Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Mycoplasma Testing Market: by Product Movement Analysis
  • Fig. 16 Global Mycoplasma Testing Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Mycoplasma Testing Market, for Kits & Reagents, 2018 - 2030 (USD Million)
  • Fig. 18 Global Mycoplasma Testing Market, for PCR Assays, 2018 - 2030 (USD Million)
  • Fig. 19 Global Mycoplasma Testing Market, for Nucleic Acid Detection Kits, 2018 - 2030 (USD Million)
  • Fig. 20 Global Mycoplasma Testing Market, for Stains, 2018 - 2030 (USD Million)
  • Fig. 21 Global Mycoplasma Testing Market, for Elimination Kits, 2018 - 2030 (USD Million)
  • Fig. 22 Global Mycoplasma Testing Market, for Standards & Controls, 2018 - 2030 (USD Million)
  • Fig. 23 Global Mycoplasma Testing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 24 Global Mycoplasma Testing Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 25 Global Mycoplasma Testing Market: Technology Movement Analysis
  • Fig. 26 Global Mycoplasma Testing Market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 27 Global Mycoplasma Testing Market, for ELISA, 2018 - 2030 (USD Million)
  • Fig. 28 Global Mycoplasma Testing Market, for Direct Assay, 2018 - 2030 (USD Million)
  • Fig. 29 Global Mycoplasma Testing Market, for Indirect Assay, 2018 - 2030 (USD Million)
  • Fig. 30 Global Mycoplasma Testing Market, for Microbial Culture Techniques, 2018 - 2030 (USD Million)
  • Fig. 31 Global Mycoplasma Testing Market, for Enzymatic Methods, 2018 - 2030 (USD Million)
  • Fig. 32 Global Mycoplasma Testing Market: Application Movement Analysis
  • Fig. 33 Global Mycoplasma Testing Market, for Cell Line Testing, 2018 - 2030 (USD Million)
  • Fig. 34 Global Mycoplasma Testing Market, for Virus Testing, 2018 - 2030 (USD Million)
  • Fig. 35 Global Mycoplasma Testing Market, for End of Production Cells Testing, 2018 - 2030 (USD Million)
  • Fig. 36 Global Mycoplasma Testing Market, for Other Applications, 2018 - 2030 (USD Million)
  • Fig. 37 Global Mycoplasma Testing Market: End-use Movement Analysis
  • Fig. 38 Global Mycoplasma Testing Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 39 Global Mycoplasma Testing Market, for Cell Banks, 2018 - 2030 (USD Million)
  • Fig. 40 Global Mycoplasma Testing Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
  • Fig. 41 Global Mycoplasma Testing Market, for Academic & Research Institutes,
  • Fig. 42 Global Mycoplasma Testing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 43 Regional Marketplace: Key Takeaways Mycoplasma Testing Market, Region 2018 - 2030 (USD Million)
  • Fig. 44 Mycoplasma Testing Market :Regional Outlook, 2023 & 2030, 2018 - 2030 (USD Million)
  • Fig. 45 North America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Germany Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 UK Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 France Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Russia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 60 China Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 61 India Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 65 Singapore Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East and Africa Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 73 UAE Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait Mycoplasma Testing Market, 2018 - 2030 (USD Million)